Type 2 Diabetes. Type 2 Diabetes. Diabetes Complications. Global Telehealth Conference 2012
|
|
|
- Leon Ford
- 9 years ago
- Views:
Transcription
1 Effects of Type 2 Diabetes Behavioural Telehealth Interventions on Glycaemic Control & Adherence: A Systematic Review Mandy Cassimatis & David Kavanagh Type 2 Diabetes Diabetes 273 Australians/ day 85 90% = Type 2 diabetes 8 th highest disease burden 3.8% of Australians $848 million/ annum 1 1. Australia s Health (2012) Rates in Australia Per cent Type 2 Diabetes Diabetes Complications Blindness Source: AIHW analysis of ABS National Health Surveys Cardiovascular disease Stroke End-stage renal disease Amputation Source: International Diabetes Federation Atlas,
2 Diabetes Complications Risk Glycosylated haemoglobin (HbA1c) level - Indicator of glucose control over past 3 months - Related to diabetes self-management 1,2 Ultimate goal = HbA1c 7.0% 3 > 50% of diabetics - sub-optimum HbA1c (>7.0%) 1. DCCT (1993) 2. UKPDS (1995) 3. Diabetes Australia 2010 Self-management Support Regular, ongoing self-management support essential 1. Barriers to effective self-care: Personal motivation, cost, non-acceptance Systemic Health system services/ professionals Rural/ regional 26% Australian diabetics inner regional; 12% -- outer regional/ remote areas 2 Poor health service access/ availability 20% Primary Healthcare providers serve c. 1/3 population 1. Fisher et al Australia s Health (2012)...Telehealth! What we know about telehealth interventions for type 2 diabetes: Good acceptability & uptake by type 2 diabetes patients. 1 Efficacy in improving psychosocial, psychological, & clinical outcomes. 2 Numerous interventions incorporate behavioural techniques. Research Question What are the effects of behavioural telehealth interventions aimed to improve glycaemic control and type 2 diabetes self-care? Aims: To conduct a systematic literature review of the effects of behavioural type 2 diabetes telehealth interventions. 1. Verhoeven et al. (2007) 2. Wu et al. (2010) 2
3 Methods The Search: Databases: Ebscohost - CINAHL (Cumulative Index to Nursing & Allied Health Literature), Medline, & PsychInfo Terms:(diabet* AND random*) AND (tele* OR mobile OR SMS or smartphone OR video* OR ehealth) Publication date: no limit Methods Study eligibility criteria: Peer-reviewed journal articles Published in English Design: Randomised controlled trials Included usual care, or active control condition Sample: adults (age 18); majority T2D Outcomes: glycaemic control + 1 diabetes self-care outcome out of: physical activity, diet, BG self-monitoring, & medication adherence Excluded: Primarily telemonitoring/ medication titration interventions; poor internal validity 49 full papers examined 14 articles on 13 studies Active intervention periods Range = 5 weeks 1,2 to 12 months 3,4,5,6 Final outcome follow-up periods Range = 3 months 7,8,9 to 12 months 3,7,4,5,10,6 post-baseline 69% of studies endpoint measures post-intervention Incoming calls trained staff/ phone coaching: 10 studies Video SMS by mobile phone: 1 study Outbound ATDM calls + nurse follow-up: 2 studies 5 studies tested short-term maintenance effects 1,7,2,10,11 Longest post-intervention & final assessment interval = 6 months Frosch et al. (2011) 2. Sigurdartottir et al. (2009) 3. Anderson et al. (2010) 4. Piette et al. (2001) 5. Piette et al. (2000) 6. Walker et al. (2011) 7. Maljanian et al. (2005) 8. Kim & Oh (2003) 9. Nesari et al. (2010) 10. Bell et al. (2012) 11. Trief et al. (2011) 3
4 Glycaemic Control 4/ 13 studies significant improvements 1,2,3,4 3 studies improved diabetes self-care 1,2,4 2 studies all 4 self-care areas improved 1,2 Dosage of intervention 2 studies reported significant intervention dosage effects on glycaemia. 3,4 Exposure to intervention duration of engagement significantly affects glycaemia outcomes. 3 Maintenance effects? 3/ 4 studies with significant outcomes tested directly post-intervention only. 1,2,4 1. Kim & Oh (2003) 2. Nesari et al. (2010) 3. Bell et al. (2012) Dietary Adherence 5/ 8 studies significant improvements 1,2,3,4,5 Studies with significant improvements VS no improvements No notable distinction between diet/ lifestyle interventions. Study sample heterogeneity a contributing factor? E.g. Trief et al. (2011) phone sessions on dietary goal setting & emotions - most participants obese. 1. Anderson et al. (2010) 2. Kim & Oh (2003) 3. Nesari et al. (2010) 5. Saco et al. (2009) Physical activity 5/8 studies significant improvements 1,2,3,4,5 3 no significant effects on glycaemia. 1,2,5 Most studies only tested effects directly post active intervention period. Delayed effects of physical activity on glycaemia? Differential impacts of resistance VS aerobic training? 1. Frosch et al. (2011) 2. Wolever et al. (2010) 3. Nesari et al. (2010) 5. Sacco et al. (2009) Blood Glucose Self-monitoring 4/ 9 studies significant improvements 1,2,3,4 Common aspect: Participants regularly reported blood glucose levels to Researcher/ Nurse -- Accountability effects? Self-report surveys used for regular BGSM reports during study & study outcome measures. Cost of increasing BGSM accounted for by 1 study Piette et al. (2001) 2. Piette et al. (2000) 3. Kim & Oh (2003) 4. Nesari et al. (2010) 5. Bell et al. (2012) 4
5 Medication Adherence 3/ 8 studies significant improvements 1,2,3 1 study reported improved glycaemia + improved self-care in 3 other areas 3 1 study ASK-20 but not Morisky 4 Medications not differentiated in general. Walker et al. (2011) - insulin-dependent VS non insulin-dependent type 2 diabetics. No significant difference was found Future studies analyse medication adherence within sub-groups. 1. Piette et al. (2000) 2. Wolever et al. (2010) 3. Nesari et al. (2010) Study Quality & Validity Internal validity moderate at best amongst studies. Allocation concealment use unclear in 5 studies. 1,2,3,4,5 Risk of exaggerated treatment effects. Small sample sizes most studies. Difficulties detecting significant treatment effects. Limited diversity in sample ethnicity External validity issues Study condition heterogeneity Trief et al. (2011) Potential bias 1. Maljanian et al. (2005) 2. Wolever et al. (2010) 3. Kim & Oh (2003) 4. Nesari et al. (2010) 5. Trief et al. (2011) Conclusions Study heterogeneity outcomes & processes Difficult to draw firm conclusions. Overall review behavioural telehealth interventions can significantly improve both glycaemic & diabetes self-care in type 2 diabetics. Physical activity & dietary adherence most improvements in response to telehealth. Conclusions Suggested study improvements: Longer post-intervention follow-up measures detect maintenance & sleeper effects. Effects of treatment dosage & duration need testing. Analyses of effects on different participant subgroups are needed. e.g. Insulin VS non-insulin dependent; HbA1c sub-groups) Effects of exposure stronger treatment effects for more intensive exposure? Community sampling 5
6 Conclusions Study methodology & reporting needs improvement e.g. blind outcome assessment & allocation concealment. More confident conclusions drawn from reviews. Overall behavioural type 2 diabetes telehealth interventions show promise of effectiveness....but... Significant developments & information about what factors are integral to effective interventions, are needed. Thanks for your attention Contact: Mandy Cassimatis [email protected] Questions? 6
Townsville NBN diabetes in-home monitoring trial Dr Karen Carlisle Townsville-Mackay Medicare Local
Townsville NBN diabetes in-home monitoring trial Dr Karen Carlisle Townsville-Mackay Medicare Local The Trial is supported by funding from the Australian Government under the Digital Regions Initiative
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
Nursing Intervention using smartphone technologies; a systematic review and meta-analysis
Digital Healthcare Empowering Europeans R. Cornet et al. (Eds.) 2015 European Federation for Medical Informatics (EFMI). This article is published online with Open Access by IOS Press and distributed under
Self-Monitoring of Blood Glucose in Noninsulin- Treated Diabetes
Summary and Conclusions Self-Monitoring of Blood Glucose in Noninsulin- Treated Diabetes A Systematic Review Swedish Council on Health Technology Assessment SBU Board of Directors and Scientific Advisory
DIABETES: Applying Evidence- Based Medicine in Telehealth George E. Dafoulas MD, MBA in HSM, PhDc e- trikala SA, Greece
DIABETES: Applying Evidence- Based Medicine in Telehealth George E. Dafoulas MD, MBA in HSM, PhDc e- trikala SA, Greece www.united4health.eu Table of Contents Overview of current status and need for Evidence
Helping people help themselves
Evidence: Helping people help themselves A review of the evidence considering whether it is worthwhile to support self-management May 2011 Identify Innovate Demonstrate Encourage Author Dr Debra de Silva
Chapter 8 - General Discussion
Chapter 8 - General Discussion 101 As stated in the introduction, the goal of type 2 diabetes care is to offer patients an integrated set of interventions in relation to life style, blood pressure regulation,
Technology Assessment
Technology Assessment Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer Technology Assessment Program Prepared for: Agency for Healthcare
The Economic Impact and Cost-Effectiveness of Glucose Monitoring
The Economic Impact and Cost-Effectiveness of Glucose Monitoring William H. Herman, MD, MPH Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes Professor of Internal Medicine and Epidemiology University
Care Planning and Goal setting in Diabetes management
Care Planning and Goal setting in Diabetes management How can we provide self-management support to people with chronic conditions? Professor Malcolm Battersby Flinders University Flinders Human Behaviour
Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12
Diabetes Introduction The attached paper is adapted from the initial background paper on Diabetes presented to the Capital and Coast District Health Board Community and Public Health Advisory Committee
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage
PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison
PATHWAYS TO TYPE 2 DIABETES Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison Overview Diabetes 101 How does diabetes work Types of diabetes Diabetes in numbers
Effectiveness of Self-Management Training in Type 2 Diabetes. A systematic review of randomized controlled trials
Reviews/Commentaries/Position R E V I E W Statements Effectiveness of Self-Management Training in Type 2 Diabetes A systematic review of randomized controlled trials SUSAN L. NORRIS, MD, MPH MICHAEL M.
Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs
T H E F A C T S A B O U T Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs Upstate New York Adults with diagnosed diabetes: 2003: 295,399 2008: 377,280 diagnosed
The effectiveness, appropriateness and meaningfulness of selfmonitoring in type 2 diabetes: a mixed methods systematic review
The effectiveness, appropriateness and meaningfulness of selfmonitoring blood glucose (SMBG) in type 2 diabetes: a mixed methods systematic review July 2009 This review was commissioned by the Australian
Self-Monitoring Of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) Aim(s) and objective(s) It is important is to ensure that people with Diabetes are given the opportunity to self monitor their blood glucose appropriately as an
Cardiovascular Disease in Diabetes
Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality
Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
Insulin myths and facts
london medicines evaluation network Insulin myths and facts Statement 1 Insulin is the last resort for patients with Type 2 diabetes After initial metformin and sulfonylurea therapy, NICE and SIGN suggest
Evaluating the Effectiveness of Physician and Clinical Pharmacist Patient Education and Disease Management in Diabetes Mellitus
Evaluating the Effectiveness of Physician and Clinical Pharmacist Patient Education and Disease Management in Diabetes Mellitus Sotheavy Vann Jackson-Hinds Comprehensive Health Center Jackson, MS Introduction
The CSIRO Total Wellbeing Diet -from lab bench to kitchen bench. Manny Noakes CSIRO Food and Nutritional Sciences
The CSIRO Total Wellbeing Diet -from lab bench to kitchen bench Manny Noakes CSIRO Food and Nutritional Sciences Any approach to weight loss? CSIRO Lower Carbohydrate Higher Protein Pattern Extensively
Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
Facts about Diabetes in Massachusetts
Facts about Diabetes in Massachusetts Diabetes is a disease in which the body does not produce or properly use insulin (a hormone used to convert sugar, starches, and other food into the energy needed
Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact
Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Task Force for the National Conference on Diabetes: The Task Force is comprised of Taking Control of
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
Diabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
Causes, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Using a Flow Sheet to Improve Performance in Treatment of Elderly Patients With Type 2 Diabetes
Special Series: AAFP Award-winning Research Papers Vol. 31, No. 5 331 Using a Flow Sheet to Improve Performance in Treatment of Elderly Patients With Type 2 Diabetes Gary Ruoff, MD; Lynn S. Gray, MD, MPH
Part B: 3 3. DIABETES MELLITUS. 3.1.1 Effects of diabetes on driving. 3.1.2 Evidence of crash risk. 3.2.1 Hypoglycaemia
3. DIABETES MELLITUS Refer also to section 6 Neurological conditions, section 2 Cardiovascular conditions, section 8 Sleep disorders section 10 Vision eye disorders. 3.1 Relevance to the driving task 3.1.1
Diabetes: Factsheet. Tower Hamlets Joint Strategic Needs Assessment 2010-2011. Executive Summary. Recommendations
Diabetes: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Diabetes is a long term condition that affects 11,859 people in Tower Hamlets, as a result of high levels
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes Introduction Self-monitoring of blood glucose (SMBG) is in widespread use among
MEDICAL POLICY POLICY TITLE DIABETIC SELF-MANAGEMENT TRAINING PROGRAM POLICY NUMBER MP- 2.076
Original Issue Date (Created): July 1, 2005 Most Recent Review Date (Revised): Effective Date: May 24, 2011 August 31, 2011- RETIRED I. POLICY Initial diabetic self-management training (DSMT) may be considered
STATE OF THE NATION. Challenges for 2015 and beyond. England
STATE OF THE NATION Challenges for 2015 and beyond England The state of the nation: diabetes in 2014 4 Care for children and young people 28 The challenges for 2015 and beyond: what needs to happen over
How good are apps for patient care? Kit Huckvale Global ehealth Unit, Imperial College London
How good are apps for patient care? Kit Huckvale Global ehealth Unit, Imperial College London Overview Effectiveness Safety Acceptability and Practicability For clinicians For patients Why apps, why now?
Getting Clinicians Involved: Testing Smartphone Applications to Promote Behavior Change in Health Care
Getting Clinicians Involved: Testing Smartphone Applications to Promote Behavior Change in Health Care Xiaomu Zhou 4 Huntington Street [email protected] Lora Appel 4 Huntington Street [email protected]
Review of diabetes care in London Health and Environment Committee
The London Assembly s Health and Environment Committee intends to review diabetes care in London. Aim of review The purpose of this review is for the Committee to understand the extent of diabetes prevalence
Diabetes Complications
Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation
Bipolar Disorder and Substance Abuse Joseph Goldberg, MD
Diabetes and Depression in Older Adults: A Telehealth Intervention Julie E. Malphurs, PhD Asst. Professor of Psychiatry and Behavioral Science Miller School of Medicine, University of Miami Research Coordinator,
Diabetes: The Numbers
Diabetes: The Numbers Changing the Way Diabetes is Treated. What is Diabetes? Diabetes is a group of diseases characterized by high levels of blood glucose (blood sugar) Diabetes can lead to serious health
Diabetes MILES Australia 2011 Survey Report
Diabetes MILES Study Diabetes MILES Australia 2011 Survey Report The Diabetes MILES Australia 2011 Survey was funded by a National Diabetes Services Scheme (NDSS) Strategic Development Grant. The NDSS
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
Interactive Voice Response Technology To Prevent Type 2 Diabetes in Cardiac Population
Interactive Voice Response Technology To Prevent Type 2 Diabetes in Cardiac Population Overview The University of Ottawa Heart Institute (UOHI) with an annual rate of 6000 admissions is committed to understanding,
Building and supporting a diabetes education workforce
Building and supporting a diabetes education workforce J Giles 1, K Visentin 1, P Phillips 2 1 Diabetes Outreach, The Queen Elizabeth Hospital and SA Department of Health, 2 Endocrine and Diabetes, The
Developing clinician competencies in self-management support for people with chronic conditions: The Flinders model
Developing clinician competencies in self-management support for people with chronic conditions: The Flinders model Introduction Self-management support is one of the 6 elements of the Chronic Care Model
CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
Diabetes Management in the Primary Care Setting
APNA Online Learning www.apna.asn.au/onlinelearning Diabetes Management in the Primary Care Setting Course Summary Diabetes Management in the Primary Care Setting is an online learning program aimed at
The Burden Of Diabetes And The Promise Of Biomedical Research
The Burden Of Diabetes And The Promise Of Biomedical Research Presented by John Anderson, MD Incoming Chair, ADA s National Advocacy Committee; Frist Clinic, Nashville, TN Type 1 Diabetes Usually diagnosed
Chronic Disease and Nursing:
Chronic Disease and Nursing: A Summary of the Issues What s the issue? Chronic diseases are now the major global disease problem facing the world and a key barrier to development, to alleviating poverty,
Type 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
Effects of macronutrients on insulin resistance and insulin requirements
Effects of macronutrients on insulin resistance and insulin requirements Dr Duane Mellor RD Assistant Professor in Dietetics, The University of Nottingham, UK Outline of Discussion Issues of determining
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD Date written: July 2012 Author: Kate Wiggins, Graeme Turner, David Johnson GUIDELINES We
Study Design and Statistical Analysis
Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing
Healthy Living with Diabetes. Diabetes Disease Management Program
Healthy Living with Diabetes Diabetes Disease Management Program Healthy Living With Diabetes Diabetes Disease Management Program Background According to recent reports the incidence of diabetes (type
Novel Trial Designs in T2D to Satisfy Regulatory Requirements for CV Safety
Novel Trial Designs in T2D to Satisfy Regulatory Requirements for CV Safety Anders Svensson MD, PhD Head of Global Clinical Development Metabolism, F Hoffmann LaRoche Ltd. Basel, Switzerland Overview of
MEDICATION THERAPY ADHERENCE CLINIC : DIABETES
MEDICATION THERAPY ADHERENCE CLINIC : DIABETES PHARMACEUTICAL SERVICES DIVISION MINISTRY OF HEALTH MALAYSIA First Edition, 2010 Pharmaceutical Services Division Ministry of Health, Malaysia ALL RIGHT RESERVED
Mindfulness-based approaches in substance abuse: a meta-analysis - preliminary results
This work was supported by a grant of the Romanian National Authority for Scientific Research, CNCS UEFISCDI, project number PN-II-ID-PCE-2012-4-0621. Mindfulness-based approaches in substance abuse: a
PEER REVIEW HISTORY ARTICLE DETAILS
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
Diabetes Education for Children With Type 1 Diabetes Mellitus and Their Families
Evidence Report/Technology Assessment Number 166 Diabetes Education for Children With Type 1 Diabetes Mellitus and Their Families Prepared for: Agency for Healthcare Research and Quality U.S. Department
Population Health Management Program
Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University
Ass Professor Frances Kay-Lambkin. NHMRC Research Fellow, National Drug and Alcohol Research Centre UNSW
Ass Professor Frances Kay-Lambkin NHMRC Research Fellow, National Drug and Alcohol Research Centre UNSW Frances Kay-Lambkin PhD National Health and Medical Research Council Research Fellow Substance Use
CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT
CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT HEALTH SERVICES AND PROGRAMS The Plan s Health Promotion and Disease Management Department seeks to improve the health and overall well-being of our
Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care
Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Services January 2015 1 IPU Submission to the Department
What privatisation means for Medibank. The increasing costs of the health system. Creating sustainability through a focus on health outcomes
IMPACT OF PRIVATISATION ON HEALTH INSURANCE Peter Derbyshire, General Manager of Strategy and Business Medibank Private Limited Development 1 The Medibank story What privatisation means for Medibank The
CASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
2012 Georgia Diabetes Burden Report: An Overview
r-,, 2012 Georgia Diabetes Burden Report: An Overview Background Diabetes and its complications are serious medical conditions disproportionately affecting vulnerable population groups including: aging
Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks
Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control
Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES
DATABASE REVIEW Grampian University Hospitals NHS Trust GRAMPIAN DIABETES SERVICES DATABASE Page 1 Contents Contents 2 Introduction 3 History 3 Overview of Database 3 Database Structure 4 Main Table Summary
Successfully starting insulin therapy in Primary Care
Successfully starting insulin therapy in Primary Care May 2014 Lorna Bingham Nurse Practitioner Candidate Endocrine, Diabetes & Research Centre Capital and Coast District Health Board [email protected]
